Stockscreener 앱 받기
3.14
6.82%
-0.23
시간 외 거래:
3.12
-0.02
-0.64%
Clearmind Medicine Inc 주식(CMND)의 최신 뉴스
Cash per share of Clearmind Medicine Inc. – FWB:CWY0 - TradingView
Tangible book value per share of Clearmind Medicine Inc. – FWB:CWY0 - TradingView
Clearmind Medicine Jumps 24.1% as Traders React to Fresh CMND-100 Updates and Upcoming June 10 Webinar - Moomoo
Clearmind Medicine Company Profile & Introduction - Moomoo
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Clearmind Medicine Inc. - MLQ.ai
CMND Stock Quote Price and Forecast - CNN
Clearmind Medicine jumps 24.1% as traders react to fresh CMND-100 updates and upcoming June 10 webinar - Quiver Quantitative
CMND Stock Jumps As Clearmind Wins Key Trial, IP Milestones - StocksToTrade
CMND Stock Jumps As Clearmind Advances Trials And Expands IP - timothysykes.com
$Clearmind Medicine (CMND.US)$ - Moomoo
Clearmind Medicine to Present CMND-100 Clinical Trial Data on June 5, 2026 - geneonline.com
Clearmind Medicine Inc. to Host Live Webinar on MEAI and Alcohol Use Disorder with Yale and Johns Hopkins on June 10, 2026 - Quiver Quantitative
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar - marketscreener.com
Clearmind Medicine Shares On The Move With Cash Question Looming - Bez Kabli
CMND News | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why Did CMND Stock Jump 40% Today? - Stocktwits
CMND Technical Analysis | Trend, Signals & Chart Patterns | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Sahm
Clearmind Medicine (CMND) Revenue BreakdownMain Composition - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Clearmind announces Japanese patent application for MEAI depression treatment By Investing.com - Investing.com South Africa
Clearmind announces Japanese patent application for MEAI depression treatment - Investing.com UK
CMND Stock Jumps As Clearmind Advances Trials And IP Push - StocksToTrade
CMND Stock Spikes As Clearmind Advances Johns Hopkins Trial - timothysykes.com
Clearmind Medicine stock surges 95% on Japan patent filing By Investing.com - Investing.com Canada
Clearmind Medicine stock surges 95% on Japan patent filing - Investing.com
Clearmind Medicine Inc. Announces Publication of Japanese Patent Application for MEAI in Depression Treatment - Quiver Quantitative
Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment - The Manila Times
Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo
CMND Stock Price, Quote & Chart | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Clearmind Medicine announces JHM-IRB approval to advance CMND-100 trial - TipRanks
Clearmind receives Johns Hopkins IRB approval for trial parts - Investing.com UK
Clearmind Medicine Advances Cmnd-100 Phase I/Ii Clinical Trial to Next Parts - marketscreener.com
Clearmind receives Johns Hopkins IRB approval for trial parts By Investing.com - Investing.com Australia
Clearmind Medicine stock gains on Johns Hopkins trial approval By Investing.com - Investing.com Nigeria
Clearmind Medicine stock gains on Johns Hopkins trial approval - Investing.com
Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts - The Manila Times
Clearmind Medicine (Nasdaq: CMND) wins IRB nod to advance CMND-100 trial - Stock Titan
Clearmind Medicine Inc. Receives IRB Approval for Phase I/II Clinical Trial of CMND-100 in Alcohol Use Disorder - Quiver Quantitative
Cash from financing activities of Clearmind Medicine Inc. – LS:A427B1 - TradingView
Net income before discontinued operations of Clearmind Medicine Inc. – LS:A427B1 - TradingView
1.27%
1.43%
자본화:
|
볼륨(24시간):